Wegovy® 1.7 mg FlexTouch is a prescription injectable treatment containing semaglutide, designed for once-weekly subcutaneous use as part of a medically supervised weight-management programme. Supplied in a convenient pre-filled FlexTouch pen, this dosage is typically used during the dose-escalation phase to support gradual adjustment. Each pack includes 1 pre-filled pen with 4 disposable needles, providing 4 weekly doses. The FlexTouch delivery system is engineered for precision, ease of use, and consistent dosing. Key Features: Strength: 1.7 mg semaglutide Administration: Once weekly Delivery: Pre-filled FlexTouch pen Pack size: 1 pen (4 doses) 4 disposable needles Manufacturer: Novo Nordisk Use: Prescription-only medicine Wegovy® should be used only under the guidance of a qualified healthcare professional.
